Abstract:Objective To observe the efficacy of Sophora moorcroftiana or albendazole alone or in combination in treating secondary hepatic hydatid disease in mice. Methods A total of 74female Kunming mice were divided into groups: 10mice were treated with saline as a blank control and the remaining mice were divided into 6groups:a high-dose Sophora moorcroftiana group[16mg/(kg·d)],a medium dose group[12mg/(kg·d)],a low dose group[8mg/(kg·d)], an albendazole group[20mg/(kg·d)],a Sophora moorcroftiana+albendazole group[8mg/(kg·d)+10mg/(kg· d)],and a model control group.An experimental animal model was created via intraperitoneal injection of a diluted suspension of protoscoleces.After three months of drug treatment,blood samples were collected from mice to determine serum IL-2,IL-6,IL-10,and IgE and levels of TNF-α,AST,and ALT.The mice were dissected,and the spleen,the thymus, and cysts were removed and weighed.The thymus index,spleen index,and inhibition rate were calculated. Results After 3months of treatment,the levels of IL-2,IL-10,and IgE and cyst weight in mice in the Sophora moorcroftiana+ albendazole group differed significantly from those in the model group(P ＜0.05).The increase in levels of AST and ALT in the Sophora moorcroftiana+albendazole group was smaller than that in the model group.A pathological examination revealed mononuclear or multinucleated giant cells in the spleen of each group.Sediment was found in the spleen and liver of the albendazole treatment group.No sediment was found in the other treatment groups(including the Sophora moorcroftiana+albendazole group). Conclusion Sophora moorcroftiana combined with albendazole has a certain level of efficacy in treating secondary hepatic hydatid disease in mice,and this combined treatment can improve the immunity of mice.Combined use of drugs can reduce the liver toxicity of a drug.

A study on treatment of secondary hepatic hydatid disease in mice with alkaloids extracted from Sophora moorcroftiana seeds